Panacea Life Sciences Holdings, Inc.
General ticker "PLSH" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $984.1K (TTM average)
Panacea Life Sciences Holdings, Inc. follows the US Stock Market performance with the rate: 25.1%.
Estimated limits based on current volatility of 10.3%: low 0.05$, high 0.07$
Factors to consider:
- Total employees count: 40 (+110.5%) as of 2023
- Top business risk factors: Dependence on CEO, Insufficient funding, Cybersecurity threats, Product liability, Technological changes
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.04$, 0.14$]
- 2025-12-31 to 2026-12-31 estimated range: [0.04$, 0.13$]
Financial Metrics affecting the PLSH estimates:
- Positive: with PPE of -1.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 68.54 > 13.24
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Positive: Investing cash flow per share per price, % of 137.72 > -0.66
Short-term PLSH quotes
Long-term PLSH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.63MM | $2.38MM | $4.11MM |
| Operating Expenses | $7.28MM | $7.93MM | $6.68MM |
| Operating Income | $-5.65MM | $-5.55MM | $-2.58MM |
| Non-Operating Income | $-3.49MM | $-2.47MM | $1.99MM |
| Interest Expense | $2.05MM | $1.56MM | $1.83MM |
| Income(Loss) | $-9.14MM | $-8.02MM | $-0.58MM |
| Profit(Loss)* | $-11.10MM | $-8.02MM | $-0.58MM |
| Stockholders Equity | $-2.14MM | $-8.29MM | $-8.25MM |
| Inventory | $4.45MM | $4.01MM | $3.66MM |
| Assets | $19.49MM | $17.98MM | $11.22MM |
| Operating Cash Flow | $-2.40MM | $-1.52MM | $0.69MM |
| Capital expenditure | $0.24MM | $0.07MM | $0.00MM |
| Investing Cash Flow | $-0.20MM | $-0.07MM | $1.38MM |
| Financing Cash Flow | $2.58MM | $1.68MM | $-0.71MM |
| Earnings Per Share** | $-0.75 | $-0.48 | $-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.